Tom Harding

1.3k total citations
9 papers, 380 citations indexed

About

Tom Harding is a scholar working on Molecular Biology, Reproductive Medicine and Social Psychology. According to data from OpenAlex, Tom Harding has authored 9 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Reproductive Medicine and 2 papers in Social Psychology. Recurrent topics in Tom Harding's work include Hypothalamic control of reproductive hormones (3 papers), Receptor Mechanisms and Signaling (3 papers) and Virus-based gene therapy research (2 papers). Tom Harding is often cited by papers focused on Hypothalamic control of reproductive hormones (3 papers), Receptor Mechanisms and Signaling (3 papers) and Virus-based gene therapy research (2 papers). Tom Harding collaborates with scholars based in United Kingdom, South Africa and United States. Tom Harding's co-authors include James B. Uney, Stafford L. Lightman, Brad J. Geddes, James N. Hislop, Robert P. Millar, Craig A. McArdle, Brigitte E. Troskie, Andrea Flynn, Jeremy M. Henley and Alison Bienemann and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Tom Harding

9 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Harding United Kingdom 9 239 152 131 52 44 9 380
Jennifer M. Mulvaney United States 8 250 1.0× 152 1.0× 226 1.7× 23 0.4× 65 1.5× 11 475
Shelley B. Nelson United States 11 389 1.6× 379 2.5× 149 1.1× 32 0.6× 15 0.3× 11 770
Sung Ho Hahm United States 11 280 1.2× 64 0.4× 28 0.2× 46 0.9× 133 3.0× 18 429
Carole Gautier‐Courteille France 13 376 1.6× 57 0.4× 82 0.6× 25 0.5× 37 0.8× 24 490
Mark D. Ware Canada 11 385 1.6× 74 0.5× 36 0.3× 74 1.4× 49 1.1× 15 583
Shoukhrat Mitalipov United States 10 501 2.1× 113 0.7× 156 1.2× 7 0.1× 42 1.0× 16 697
Vivienne Wilkins United Kingdom 6 340 1.4× 195 1.3× 229 1.7× 17 0.3× 21 0.5× 6 608
Leonard Cheung United States 10 219 0.9× 128 0.8× 39 0.3× 18 0.3× 13 0.3× 18 394
Yotam Kaufman Israel 11 390 1.6× 335 2.2× 26 0.2× 49 0.9× 28 0.6× 14 599
Jeffrey L. Pitman United States 8 270 1.1× 161 1.1× 31 0.2× 12 0.2× 64 1.5× 8 382

Countries citing papers authored by Tom Harding

Since Specialization
Citations

This map shows the geographic impact of Tom Harding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Harding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Harding more than expected).

Fields of papers citing papers by Tom Harding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Harding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Harding. The network helps show where Tom Harding may publish in the future.

Co-authorship network of co-authors of Tom Harding

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Harding. A scholar is included among the top collaborators of Tom Harding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Harding. Tom Harding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zaid, Tarrik M., Tsz-Lun Yeung, Melissa S. Thompson, et al.. (2013). Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 19(4). 809–820. 74 indexed citations
2.
Gerritsen, W.R., Alfons J. van den Eertwegh, Tanja D. de Gruijl, et al.. (2007). Biochemical and immunologic correlates of clinical response in a combination trial of the GM-CSF-gene transduced allogeneic prostate cancer immunotherapy and ipilimumab in patients with metastatic hormone-refractory prostate cancer (mHRPC). Journal of Clinical Oncology. 25(18_suppl). 5120–5120. 15 indexed citations
3.
Wong, Liang‐Fong, Tom Harding, James B. Uney, & David Murphy. (2003). cAMP-dependent protein kinase A mediation of vasopressin gene expression in the hypothalamus of the osmotically challenged rat. Molecular and Cellular Neuroscience. 24(1). 82–90. 12 indexed citations
4.
Hislop, James N., Tom Harding, James B. Uney, et al.. (2001). Signaling and Antiproliferative Effects Mediated by GnRH Receptors After Expression in Breast Cancer Cells Using Recombinant Adenovirus. Endocrinology. 142(11). 4663–4672. 40 indexed citations
5.
Hislop, James N., Andrea Flynn, Tom Harding, et al.. (2001). Differential Internalization of Mammalian and Non-mammalian Gonadotropin-releasing Hormone Receptors. Journal of Biological Chemistry. 276(43). 39685–39694. 61 indexed citations
7.
Hislop, James N., Tom Harding, James B. Uney, et al.. (2000). Desensitization and Internalization of Human andXenopusGonadotropin-Releasing Hormone Receptors Expressed in αT4 Pituitary Cells Using Recombinant Adenovirus1. Endocrinology. 141(12). 4564–4575. 50 indexed citations
8.
Geddes, Brad J., Tom Harding, Stafford L. Lightman, & James B. Uney. (1999). Assessing Viral Gene Therapy in Neuroendocrine Models. Frontiers in Neuroendocrinology. 20(4). 296–316. 10 indexed citations
9.
Geddes, Brad J., Tom Harding, Stafford L. Lightman, & James B. Uney. (1997). Long-term gene therapy in the CNS: Reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin. Nature Medicine. 3(12). 1402–1404. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026